M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_38903

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_38903 37 0.76 Mlig455_055963, Mlig455_056073

Neo: -

Age: -

 KCNK5

Mlig455_055963 {REF} {Length: 986} {Pfam: Ion channel [PF07885.18, score=106.1]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=133, Expect=4e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=127, Expect=9e-33]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=108, Expect=6e-26]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=8e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]}

Mlig455_056073 {REF} {Length: 1284} {Pfam: Ion channel [PF07885.18, score=106.2]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=132, Expect=6e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=126, Expect=1e-32]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=106, Expect=2e-25]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=9e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} {RNA1310_133484}

Cumulative graph for MligTC455_38903

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.466 1.246 1.00000 1.00000
RegionR2 3.249 1.246 0.37661 0.77136
RegionR3 1.478 1.246 0.45989 0.96963
RegionR4 1.925 1.246 0.57409 0.89182
RegionR5 -0.829 1.246 0.89849 1.00000
RegionR6 -2.914 1.246 1.00000 1.00000
RegionR7 1.897 1.246 0.38756 1.00000
RegionR8 -2.341 1.246 0.99956 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 -1.038 1.246 1.00000 1.00000
RegenerationR2 -0.452 1.246 0.86880 1.00000
RegenerationR3 -2.149 1.246 0.42373 0.81776
RegenerationR4 -3.015 1.246 0.58010 0.90555
RegenerationR5 -0.523 1.246 0.97629 1.00000
RegenerationR6 0.85 1.246 0.57821 0.85668
RegenerationBL -2.296 1.246 1.00000 1.00000
RegenerationTP -2.758 1.246 1.00000 1.00000


Genes with expression patterns similar to MligTC455_38903

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_38903 37 0.76 Mlig455_055963, Mlig455_056073

Neo: -

Age: -

 KCNK5 5 - 1.000 1.000 1.000 1.000 1.000

Mlig455_055963 {REF} {Length: 986} {Pfam: Ion channel [PF07885.18, score=106.1]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=133, Expect=4e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=127, Expect=9e-33]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=108, Expect=6e-26]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=8e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]}

Mlig455_056073 {REF} {Length: 1284} {Pfam: Ion channel [PF07885.18, score=106.2]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=132, Expect=6e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=126, Expect=1e-32]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=106, Expect=2e-25]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=9e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} {RNA1310_133484}
2. MligTC455_43326 39 0.8 Mlig455_057987

Neo: -

Age: -

 3.505 - - 0.792 0.900 0.816 0.997 Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308}
3. MligTC455_26091 161 3.36 Mlig455_047190

Neo: -

Age: -

Region-enriched R2: 4.521/0.00020

 3.362 - - 0.705 0.957 0.750 0.950 Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719}
4. MligTC455_14898 41 0.86 Mlig455_011988

Neo: -

Age: -

 3.222 - - 0.728 0.813 0.701 0.980 Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1}
5. MligTC455_29153 62 1.28 Mlig455_018743, Mlig455_018911

Neo: -

Age: -

 2.649 - - 0.772 0.903 - 0.974

Mlig455_018743 {REF} {Length: 1064} {RNA1509_38365} {RNA1310_117516} {RNA815_19813}

Mlig455_018911 {REF} {Length: 2829} {RNA1509_38365} {RNA1310_117516} {RNA815_28950}
6. MligTC455_20088 39 0.81 Mlig455_017821

Neo: -

Age: Up-Down-Down

 GLIPR1 2.648 - - - 0.831 0.837 0.980 Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891}
7. MligTC455_49855 19 0.39 Mlig455_020555, Mlig455_020604

Neo: -

Age: -

 2.632 - - 0.722 0.930 - 0.980

Mlig455_020555 {REF} {Length: 1515} {RNA1509_44515} {RNA1310_26152} {RNA815_8882}

Mlig455_020604 {REF} {Length: 370} {Pfam: PAN domain [PF00024.28, score=19.8]} {RNA1509_44515} {RNA1310_26152} {RNA815_8882}
8. MligTC455_35802 114 2.38 Mlig455_051876, Mlig455_051902, Mlig455_053140

Neo: -

Age: -

 CACNA2D1 2.616 - - 0.926 - 0.719 0.971

Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380}

Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878}

Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878}
9. MligTC455_24952 637 13.28 Mlig455_054178, Mlig455_060727

Neo: -

Age: Down-Up-Down

Region-specific R2: 4.165

Region-enriched R2: 3.160/0.00003

Regeneration-downregulated BL: -4.774

Regeneration-depleted BL: -4.774

 CCDC169 2.6 - - - 0.950 0.725 0.925

Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545}

Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545}
10. MligTC455_54019 59 1.23 Mlig455_050979

Neo: -

Age: logFC(26M/2M)=0.902

 DEGS2 2.595 - - 0.838 0.793 - 0.964 Mlig455_050979 {REF} {Length: 2343} {Pfam: Fatty acid desaturase [PF00487.26, score=84.5]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=59.9]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=332, Expect=1e-111]} {Mouse: ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=320, Expect=3e-107]; ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=304, Expect=8e-101]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=354, Expect=1e-120]} {Celegans: WBGene00013197, ttm-5, Putative sphingolipid delta(4)-desaturase/C4-monooxygenase, [Score=325, Expect=1e-108]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=422, Expect=6e-147]} {RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1310_11518, RNA1509_11966, RNA1509_33417, RNA1509_59878} {RNA1509_11966, RNA1509_33417, RNA1509_59878, RNA815_6718}
11. MligTC455_44120 125 2.61 Mlig455_041513

Neo: -

Age: Up-Down-Down

Region-enriched R2: 7.169/0.00020

 2.546 - - 0.716 0.864 - 0.966 Mlig455_041513 {REF} {Length: 644} {NoTransDecoderORF} {RNA1310_39164} {RNA815_4344}
12. MligTC455_51759 40 0.83 Mlig455_026782

Neo: -

Age: -

Region-enriched R4: 4.435/0.02831

 CNBD2 2.525 - - 0.754 - 0.799 0.972 Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620}
13. MligTC455_33463 240 4.99 Mlig455_023684

Neo: -

Age: Up-Down-Down

Region-enriched R2: 6.110/0.00054

 PKD1L2 2.512 - - 0.767 0.764 - 0.981 Mlig455_023684 {REF} {Length: 12137} {Pfam: Polycystin cation channel [PF08016.14, score=271.5]; PKD domain [PF00801.22, score=88.3]; PLAT/LH2 domain [PF01477.25, score=72.6]; PKD domain [PF18911.2, score=49.9]; Ion transport protein [PF00520.33, score=46.0]; F5/8 type C domain [PF00754.27, score=33.9]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [RH, Score=263, Expect=2e-69]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=272, Expect=3e-72]} {Dmel: FBgn0050048, CG30048, [Score=57.4, Expect=3e-07]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=144, Expect=2e-33]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=518, Expect=3e-147]} {RNA1509_5488} {RNA1310_100} {RNA815_3211}
14. MligTC455_49434 157 3.26 Mlig455_068252, Mlig455_068272

Neo: -

Age: -

 2.506 - - 0.789 - 0.737 0.980

Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052}

Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052}
15. MligTC455_17363 62 1.28 Mlig455_003936

Neo: -

Age: -

 2.503 - - 0.757 - 0.766 0.980 Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646}
16. MligTC455_23977 63 1.31 Mlig455_012689

Neo: -

Age: -

Regeneration-downregulated R5: -6.245

Regeneration-depleted R5: -6.245

 DRD2 2.503 - - - 0.986 0.764 0.753 Mlig455_012689 {REF} {Length: 2124} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=191.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=32.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=28.4]} {Human: ENSG00000149295, DRD2, dopamine receptor D2, [Score=170, Expect=1e-46]} {Mouse: ENSMUSG00000032259, Drd2, dopamine receptor D2, [Score=168, Expect=4e-46]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [RH, Score=160, Expect=4e-43]} {Celegans: WBGene00006475, tyra-3, TYRAmine receptor, [Score=159, Expect=2e-42]} {Smed: dd_Smed_v6_27884_0_1, dd_Smed_v6_27884_0_1, [Score=198, Expect=7e-57]} {RNA1310_28840} {RNA815_30584}
17. MligTC455_40353 39 0.82 Mlig455_024525

Neo: -

Age: -

 2.493 - - 0.741 0.791 - 0.961 Mlig455_024525 {REF} {Length: 1158} {RNA1310_29008}
18. MligTC455_29412 46 0.96 Mlig455_000627, Mlig455_008268, Mlig455_040614

Neo: -

Age: Up-Down-Up

 2.483 - - 0.770 - 0.737 0.976

Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942}

Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1}

Mlig455_040614 {REF} {Length: 1016}
19. MligTC455_17178 54 1.12 Mlig455_067758

Neo: -

Age: -

Region-enriched R2: 7.471/0.00007

 2.478 - - 0.777 - 0.732 0.969 Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1}
20. MligTC455_30463 95 1.98 Mlig455_000250, Mlig455_058521, Mlig455_058532

Neo: -

Age: -

 2.475 - - 0.778 - 0.744 0.953

Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085}

Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085}

Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085}
21. MligTC455_40687 28 0.58 Mlig455_040563, Mlig455_062078

Neo: -

Age: -

 PDE1C 2.468 - - 0.794 - 0.721 0.953

Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402}

Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704}
22. MligTC455_39222 213 4.44 Mlig455_064653, Mlig455_064686

Neo: -

Age: -

Region-enriched R2: 4.317/0.00597

 2.463 - - 0.763 - 0.724 0.976

Mlig455_064653 {REF} {Length: 2836} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.9, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=7e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_56255} {RNA1310_13407} {RNA815_38407}

Mlig455_064686 {REF} {Length: 3820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.5, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_50956} {RNA1310_13407} {RNA815_38407}
23. MligTC455_14856 14 0.29 Mlig455_023184

Neo: -

Age: -

 ANGPTL7 2.449 - - 0.763 0.727 - 0.959 Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1}
24. MligTC455_46188 25 0.51 Mlig455_039664, Mlig455_039727

Neo: -

Age: -

 2.441 - - 0.740 - 0.721 0.980

Mlig455_039664 {REF} {Length: 1353}

Mlig455_039727 {REF} {Length: 1348}
25. MligTC455_50931 28 0.58 Mlig455_046985, Mlig455_047028

Neo: -

Age: -

 FCN2 2.438 - - 0.733 - 0.725 0.980

Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}

Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881}
26. MligTC455_17138 283 5.89 Mlig455_029728

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.646

Region-specific R2: 4.824

Region-enriched R2: 5.583/0.00000

 LRRCC1 2.433 - - 0.700 0.783 - 0.950 Mlig455_029728 {REF} {Length: 1372} {Pfam: Heat shock factor binding protein 1 [PF06825.14, score=68.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=67.8]; Leucine rich repeat [PF13855.8, score=44.9]; Leucine-rich repeat [PF14580.8, score=35.0]; Leucine Rich repeat [PF13516.8, score=21.5]} {Human: ENSG00000133739, LRRCC1, leucine rich repeat and coiled-coil centrosomal protein 1, [RH, Score=402, Expect=3e-122]} {Mouse: ENSMUSG00000027550, Lrrcc1, leucine rich repeat and coiled-coil domain containing 1, [RH, Score=387, Expect=3e-117]} {Dmel: FBgn0032429, CG5446, [Score=66.6, Expect=3e-13]} {Celegans: WBGene00189952, K10D2.8, [Score=65.1, Expect=8e-11]} {Smed: dd_Smed_v6_10086_0_1, dd_Smed_v6_10086_0_1, [RH, Score=443, Expect=2e-139]} {RNA1509_31405, RNA1509_32465} {RNA1310_70756, RNA1509_31405, RNA1509_32465} {RNA1509_31405, RNA1509_32465, RNA815_37567}
27. MligTC455_21353 452 9.41 Mlig455_004209, Mlig455_004221

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.406

 2.414 - - 0.758 0.704 - 0.952

Mlig455_004209 {REF} {Length: 1786} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [RH, Score=100, Expect=1e-24]} {RNA1509_45598} {RNA1310_22701, RNA1509_45598} {RNA1509_45598, RNA815_19949}

Mlig455_004221 {REF} {Length: 1440} {Smed: dd_Smed_v6_11196_0_1, dd_Smed_v6_11196_0_1, [Score=84.0, Expect=9e-19]} {RNA1509_45598} {RNA1310_32084} {RNA815_19949}
28. MligTC455_04118 14 0.29 Mlig455_035415

Neo: -

Age: -

 1.972 - - - - 0.974 0.998 Mlig455_035415 {REF} {Length: 828} {RNA1310_20357.2} {RNA815_20589}
29. MligTC455_49878 31 0.65 Mlig455_050656

Neo: -

Age: -

 CHRNA10 1.956 - - 0.977 - - 0.979 Mlig455_050656 {REF} {Length: 1810} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=89.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=81.7]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=145, Expect=8e-38]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=7e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=4e-37]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=142, Expect=9e-37]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=143, Expect=9e-38]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=7e-37]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=139, Expect=4e-36]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=134, Expect=3e-34]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=126, Expect=9e-32]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=133, Expect=3e-34]} {RNA1310_26175} {RNA815_7952}
30. MligTC455_33854 41 0.85 Mlig455_031601

Neo: -

Age: -

Region-enriched R2: 5.730/0.00808

 1.954 - - 0.969 - - 0.985 Mlig455_031601 {REF} {Length: 1072} {RNA1310_42312} {RNA815_56269}
31. MligTC455_16962 22 0.45 Mlig455_013331

Neo: -

Age: -

 PXDN 1.949 - - 0.964 - - 0.985 Mlig455_013331 {REF} {Length: 2939} {Pfam: Immunoglobulin I-set domain [PF07679.18, score=51.7]; Immunoglobulin domain [PF13927.8, score=47.8]; Immunoglobulin domain [PF00047.27, score=41.8]; Immunoglobulin domain [PF13895.8, score=34.9]; CD80-like C2-set immunoglobulin domain [PF08205.14, score=22.3]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=53.9, Expect=4e-07]; ENSG00000174498, IGDCC3, immunoglobulin superfamily DCC subclass member 3, [Score=53.1, Expect=9e-07]; ENSG00000113805, CNTN3, contactin 3, [Score=52.0, Expect=2e-06]; ENSG00000155657, TTN, titin, [Score=51.6, Expect=3e-06]} {Mouse: ENSMUSG00000051747, Ttn, titin, [Score=54.3, Expect=3e-07]; ENSMUSG00000020674, Pxdn, peroxidasin, [Score=52.8, Expect=8e-07]; ENSMUSG00000032394, Igdcc3, immunoglobulin superfamily, DCC subclass, member 3, [Score=52.8, Expect=8e-07]; ENSMUSG00000030075, Cntn3, contactin 3, [Score=52.8, Expect=9e-07]} {Dmel: FBgn0003984, vn, vein, [Score=63.5, Expect=2e-10]} {Celegans: WBGene00006776, unc-40, Unc-40 protein, [Score=53.9, Expect=2e-07]} {Smed: dd_Smed_v6_15790_0_1, dd_Smed_v6_15790_0_1, [RH, Score=70.5, Expect=3e-13]} {RNA1310_57623} {RNA815_38366}
32. MligTC455_54633 10 0.22 Mlig455_016883

Neo: -

Age: -

 1.946 - - - - 0.981 0.965 Mlig455_016883 {REF} {Length: 283} {NoTransDecoderORF}
33. MligTC455_10886 28 0.58 Mlig455_046889

Neo: -

Age: -

 1.941 - - - - 0.971 0.970 Mlig455_046889 {REF} {Length: 1896} {NoTransDecoderORF}
34. MligTC455_17412 44 0.91 Mlig455_069737

Neo: -

Age: -

Region-enriched R2: 5.062/0.00923

 1.932 - - 0.960 - - 0.972 Mlig455_069737 {REF} {Length: 1628} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=42.8]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=3e-14]} {RNA1310_45758} {RNA815_42912}
35. MligTC455_35933 19 0.4 Mlig455_033271

Neo: -

Age: -

 1.919 - - - - 0.943 0.976 Mlig455_033271 {REF} {Length: 1256} {RNA1310_22041} {RNA815_26444}
36. MligTC455_09455 51 1.06 Mlig455_029990

Neo: -

Age: -

Region-enriched R2: 4.710/0.00601

 1.913 - - 0.923 - - 0.990 Mlig455_029990 {REF} {Length: 3817} {Mouse: ENSMUSG00000090546, Cdr1, cerebellar degeneration related antigen 1, [Score=63.2, Expect=8e-10]} {Celegans: WBGene00013762, Y113G7B.12, [Score=58.2, Expect=2e-08]} {RNA1509_44134} {RNA1310_28496} {RNA815_11143}
37. MligTC455_16372 169 3.51 Mlig455_016886, Mlig455_031921, Mlig455_038984

Neo: -

Age: Up-Down-Down

Region-enriched R7: 3.380/0.02563

 DNAH5, TNC 1.908 - - - 0.959 - 0.949

Mlig455_016886 {REF} {Length: 16127} {Pfam: Dynein heavy chain, N-terminal region 1 [PF08385.14, score=524.5]; Dynein heavy chain, N-terminal region 2 [PF08393.15, score=384.9]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=333.6]; P-loop containing dynein motor region D4 [PF12780.9, score=212.5]; Dynein heavy chain C-terminal domain [PF18199.3, score=194.5]; P-loop containing dynein motor region [PF12775.9, score=179.4]; ATP-binding dynein motor region [PF12781.9, score=166.7]; Dynein heavy chain AAA lid domain [PF18198.3, score=119.5]; Microtubule-binding stalk of dynein motor [PF12777.9, score=108.6]; AAA domain (dynein-related subfamily) [PF07728.16, score=72.9]; Dynein heavy chain AAA lid domain [PF17852.3, score=70.1]; AAA+ lid domain [PF17857.3, score=41.8]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=40.1]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=33.7]; AAA domain [PF13401.8, score=25.3]; AAA domain [PF13238.8, score=24.8]; AAA domain [PF13671.8, score=20.4]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [Score=3448, Expect=0.0]; ENSG00000124721, DNAH8, dynein axonemal heavy chain 8, [Score=3316, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [Score=3446, Expect=0.0]; ENSMUSG00000033826, Dnah8, dynein, axonemal, heavy chain 8, [Score=3292, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [Score=2897, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=498, Expect=2e-140]} {Smed: dd_Smed_v6_4176_0_1, dd_Smed_v6_4176_0_1, [Score=3967, Expect=0.0]} {RNA1509_43317} {RNA1310_25212} {RNA815_36008}

Mlig455_031921 {REF} {Length: 13106} {Pfam: Dynein heavy chain, N-terminal region 2 [PF08393.15, score=385.9]; Hydrolytic ATP binding site of dynein motor region [PF12774.9, score=334.7]; P-loop containing dynein motor region D4 [PF12780.9, score=212.9]; Dynein heavy chain C-terminal domain [PF18199.3, score=195.8]; P-loop containing dynein motor region [PF12775.9, score=180.5]; ATP-binding dynein motor region [PF12781.9, score=167.8]; Dynein heavy chain AAA lid domain [PF18198.3, score=119.9]; AAA domain (dynein-related subfamily) [PF07728.16, score=74.0]; Dynein heavy chain AAA lid domain [PF17852.3, score=69.7]; Microtubule-binding stalk of dynein motor [PF12777.9, score=66.4]; AAA+ lid domain [PF17857.3, score=42.2]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=41.5]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=35.0]; AAA domain [PF13401.8, score=27.7]; AAA domain [PF13238.8, score=25.6]; AAA domain [PF13671.8, score=21.2]; IstB-like ATP binding protein [PF01695.19, score=19.4]} {Human: ENSG00000039139, DNAH5, dynein axonemal heavy chain 5, [Score=2729, Expect=0.0]; ENSG00000124721, DNAH8, dynein axonemal heavy chain 8, [Score=2653, Expect=0.0]} {Mouse: ENSMUSG00000022262, Dnah5, dynein, axonemal, heavy chain 5, [Score=2721, Expect=0.0]; ENSMUSG00000033826, Dnah8, dynein, axonemal, heavy chain 8, [Score=2630, Expect=0.0]} {Dmel: FBgn0037726, CG9492, [Score=2480, Expect=0.0]} {Celegans: WBGene00000962, dhc-1, Dynein heavy chain, cytoplasmic, [Score=499, Expect=3e-141]} {Smed: dd_Smed_v6_4176_0_1, dd_Smed_v6_4176_0_1, [Score=2977, Expect=0.0]} {RNA1509_43317} {RNA1310_33723} {RNA815_36008}

Mlig455_038984 {REF} {Length: 864} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=91.8]} {Human: ENSG00000041982, TNC, tenascin C, [Score=86.3, Expect=2e-18]; ENSG00000116147, TNR, tenascin R, [Score=85.5, Expect=3e-18]} {Mouse: ENSMUSG00000028364, Tnc, tenascin C, [Score=85.9, Expect=2e-18]; ENSMUSG00000015829, Tnr, tenascin R, [Score=83.6, Expect=1e-17]; ENSMUSG00000026938, Fcna, ficolin A, [Score=82.4, Expect=8e-18]} {Dmel: FBgn0034160, CG5550, [Score=96.3, Expect=2e-23]} {Celegans: WBGene00020516, T15B7.1, [Score=47.0, Expect=6e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=76.3, Expect=1e-15]} {RNA1310_35490}
38. MligTC455_14605 9 0.2 Mlig455_014306

Neo: -

Age: -

 1.907 - - - 0.936 - 0.971 Mlig455_014306 {REF} {Length: 2195} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=87.6]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=52.8, Expect=3e-07]} {Smed: dd_Smed_v6_14355_0_1, dd_Smed_v6_14355_0_1, [Score=105, Expect=2e-24]} {RNA1310_19428.1} {RNA815_22602}
39. MligTC455_45910 20 0.42 Mlig455_068873

Neo: -

Age: -

 ANGPT4 1.898 - - - 0.921 - 0.977 Mlig455_068873 {REF} {Length: 1013} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=111.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=95.1, Expect=7e-22]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=91.3, Expect=2e-20]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=93.6, Expect=3e-22]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=93.2, Expect=1e-21]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=90.9, Expect=1e-20]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=89.4, Expect=4e-20]} {Dmel: FBgn0087011, CG41520, [Score=87.0, Expect=2e-19]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=7e-26]} {RNA1310_32728} {RNA815_23388}
40. MligTC455_11701 54 1.12 Mlig455_042837, Mlig455_045855, Mlig455_045871

Neo: -

Age: -

 1.894 - - - - 0.914 0.980

Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819}

Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819}

Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819}
41. MligTC455_19775 36 0.74 Mlig455_060359

Neo: -

Age: -

 FCN1 1.892 - - - - 0.963 0.929 Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536}
42. MligTC455_28575 27 0.55 Mlig455_028366, Mlig455_052765

Neo: -

Age: -

 1.889 - - - - 0.915 0.974

Mlig455_028366 {REF} {Length: 771} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_22744} {RNA815_55880}

Mlig455_052765 {REF} {Length: 1415} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_15798} {RNA1310_22744} {RNA815_55880}
43. MligTC455_49769 11 0.23 Mlig455_004340, Mlig455_004350

Neo: -

Age: Up-Down-Down

 ANOS1 1.888 - - - - 0.908 0.980

Mlig455_004340 {REF} {Length: 3275} {Pfam: Fibronectin type III domain [PF00041.23, score=59.5]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=114, Expect=6e-26]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=83.2, Expect=2e-16]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=152, Expect=2e-38]} {RNA1509_44032} {RNA1310_20852} {RNA815_15013}

Mlig455_004350 {REF} {Length: 3028} {Pfam: Fibronectin type III domain [PF00041.23, score=83.9]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=126, Expect=1e-29]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=85.9, Expect=4e-17]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=183, Expect=3e-48]} {RNA1509_44032} {RNA1310_20852, RNA1509_44032} {RNA1509_44032, RNA815_15013}
44. MligTC455_25408 35 0.72 Mlig455_026127

Neo: -

Age: Up-Down-Down

 1.887 - - - 0.924 - 0.963 Mlig455_026127 {REF} {Length: 2873} {Pfam: Variant SH3 domain [PF07653.19, score=21.9]; RIM-binding protein of the cytomatrix active zone [PF10174.11, score=16.9]} {Mouse: ENSMUSG00000034156, Tspoap1, TSPO associated protein 1, [Score=55.1, Expect=4e-07]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [Score=140, Expect=5e-35]} {RNA1509_45271} {RNA1310_5741} {RNA815_46868}
45. MligTC455_43782 48 1 Mlig455_044623, Mlig455_044681

Neo: -

Age: Up-Down-Up

 1.887 - - - - 0.960 0.927

Mlig455_044623 {REF} {Length: 2203} {RNA1310_60578} {RNA815_63573}

Mlig455_044681 {REF} {Length: 2217} {Pfam: Glycine rich protein [PF12810.9, score=37.4]} {RNA1310_60578} {RNA815_63573}
46. MligTC455_40767 11 0.23 Mlig455_052938

Neo: -

Age: -

 1.884 - - 0.904 - - 0.980 Mlig455_052938 {REF} {Length: 1728} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=26.2]; PAN domain [PF00024.28, score=20.2]} {RNA1509_17891} {RNA1310_58949} {RNA815_4614.1}
47. MligTC455_12999 17 0.34 Mlig455_056142

Neo: -

Age: logFC(26M/2M)=-0.895

 1.866 - - - - 0.982 0.884 Mlig455_056142 {REF} {Length: 842} {NoTransDecoderORF} {RNA1509_2486} {RNA1310_82742} {RNA815_5954.1}
48. MligTC455_15949 37 0.76 Mlig455_059880

Neo: -

Age: -

 1.86 - - - 0.907 - 0.953 Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903}
49. MligTC455_45909 21 0.43 Mlig455_048634, Mlig455_068858

Neo: -

Age: -

 ANGPT4 1.854 - - - 0.891 - 0.963

Mlig455_048634 {REF} {Length: 490} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=169.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=134, Expect=3e-35]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=127, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=126, Expect=1e-32]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=124, Expect=6e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=123, Expect=8e-32]; ENSMUSG00000033327, Tnxb, tenascin XB, [Score=122, Expect=1e-30]; ENSMUSG00000031465, Angpt2, angiopoietin 2, [Score=122, Expect=3e-31]} {Dmel: FBgn0087011, CG41520, [Score=108, Expect=3e-26]} {Celegans: WBGene00020516, T15B7.1, [Score=66.2, Expect=3e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=121, Expect=5e-31]} {RNA1310_35640.1}

Mlig455_068858 {REF} {Length: 1227} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=169.7]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=134, Expect=3e-35]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=127, Expect=3e-34]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=126, Expect=1e-32]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=124, Expect=6e-32]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=123, Expect=8e-32]; ENSMUSG00000033327, Tnxb, tenascin XB, [Score=122, Expect=1e-30]; ENSMUSG00000031465, Angpt2, angiopoietin 2, [Score=122, Expect=3e-31]} {Dmel: FBgn0087011, CG41520, [Score=108, Expect=3e-26]} {Celegans: WBGene00020516, T15B7.1, [Score=66.2, Expect=3e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=121, Expect=5e-31]} {RNA1310_35640.1} {RNA815_23388}
50. MligTC455_13635 16 0.33 Mlig455_014568

Neo: -

Age: -

 1.853 - - - - 0.888 0.965 Mlig455_014568 {REF} {Length: 1825}
51. MligTC455_39064 110 2.28 Mlig455_000222, Mlig455_058480

Neo: Irradiation

Age: -

Region-enriched R2: 5.418/0.00017

 OSBPL1A 1.851 - - 0.892 - - 0.959

Mlig455_000222 {REF} {Length: 2113} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_7740}

Mlig455_058480 {REF} {Length: 2888} {TRANSSPLICED} {Pfam: Oxysterol-binding protein [PF01237.20, score=414.5]} {Human: ENSG00000141447, OSBPL1A, oxysterol binding protein like 1A, [RH, Score=375, Expect=2e-116]; ENSG00000130703, OSBPL2, oxysterol binding protein like 2, [RH, Score=357, Expect=8e-115]} {Mouse: ENSMUSG00000044252, Osbpl1a, oxysterol binding protein-like 1A, [RH, Score=378, Expect=4e-122]; ENSMUSG00000039050, Osbpl2, oxysterol binding protein-like 2, [RH, Score=367, Expect=6e-119]} {Dmel: FBgn0034951, CG3860, [RH, Score=409, Expect=1e-135]} {Celegans: WBGene00008832, obr-2, Oxysterol Binding protein (OSBP) Related, [RH, Score=239, Expect=3e-71]} {Smed: dd_Smed_v6_3179_0_1, dd_Smed_v6_3179_0_1, [RH, Score=385, Expect=3e-126]} {RNA1509_29630} {RNA1310_38654} {RNA815_26411}
52. MligTC455_50464 64 1.34 Mlig455_007906, Mlig455_008010

Neo: -

Age: -

 1.846 - - - 0.873 - 0.973

Mlig455_007906 {REF} {Length: 3294} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1}

Mlig455_008010 {REF} {Length: 1139} {RNA1509_46103} {RNA1310_23886.1} {RNA815_8813.1}
53. MligTC455_55843 12 0.25 Mlig455_014566

Neo: -

Age: -

Regeneration-upregulated R2: 4.698

Regeneration-enriched R2: 4.698

 1.845 - - - - 0.876 0.969 Mlig455_014566 {REF} {Length: 2456} {Pfam: C2 domain [PF00168.32, score=30.3]}
54. MligTC455_14307 7 0.14 Mlig455_010232

Neo: -

Age: -

 1.844 - - - - 0.844 1.000 Mlig455_010232 {REF} {Length: 2384} {Pfam: Endonuclease-reverse transcriptase [PF14529.8, score=55.8]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=20.8]; PHD-finger [PF00628.31, score=19.7]} {RNA1310_115972}
55. MligTC455_12023 10 0.21 Mlig455_069913

Neo: -

Age: logFC(26M/2M)=-0.471

 IQCA1 1.84 - - - - 0.866 0.974 Mlig455_069913 {REF} {Length: 3208} {Pfam: ATPase family associated with various cellular activities (AAA) [PF00004.31, score=46.4]} {Human: ENSG00000132321, IQCA1, IQ motif containing with AAA domain 1, [RH, Score=719, Expect=0.0]} {Mouse: ENSMUSG00000026301, Iqca, IQ motif containing with AAA domain, [RH, Score=704, Expect=0.0]} {Dmel: FBgn0037712, CG16789, [RH, Score=523, Expect=3e-173]} {Smed: dd_Smed_v6_9484_0_1, dd_Smed_v6_9484_0_1, [RH, Score=439, Expect=2e-145]} {RNA1509_29051} {RNA1310_11400.1} {RNA815_11137.1}
56. MligTC455_47261 1918 39.96 Mlig455_033946

Neo: -

Age: -

Region-specific R2: 4.808

Region-enriched R2: 4.545/0.00000

 1.838 - - - 0.865 - 0.973 Mlig455_033946 {REF} {Length: 2098} {RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1310_36725.1, RNA1509_18239, RNA1509_26992, RNA1509_32368} {RNA1509_18239, RNA1509_26992, RNA1509_32368, RNA815_10268.1}
57. MligTC455_46430 62 1.29 Mlig455_057117, Mlig455_069301

Neo: -

Age: -

 GUCY2F 1.837 - - 0.852 - - 0.985

Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108}

Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181}
58. MligTC455_55986 9 0.2 Mlig455_047193

Neo: -

Age: -

 1.837 - - - - 0.856 0.981 Mlig455_047193 {REF} {Length: 348} {NoTransDecoderORF}
59. MligTC455_17299 538 11.21 Mlig455_036559, Mlig455_057787

Neo: -

Age: -

Region-enriched R2: 5.046/0.00000
Region-enriched R3: 3.527/0.00004

 1.828 - - - - 0.855 0.973

Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706}

Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706}
60. MligTC455_17520 34 0.71 Mlig455_022340

Neo: -

Age: -

 1.827 - - 0.830 - - 0.997 Mlig455_022340 {REF} {Length: 878} {Pfam: WSC domain [PF01822.21, score=52.4]; PAN domain [PF00024.28, score=24.0]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=50.4, Expect=3e-07]} {RNA1509_43359} {RNA1310_27550.1} {RNA815_22520}
61. MligTC455_10546 13 0.27 Mlig455_011137

Neo: -

Age: -

 1.81 - - - - 0.838 0.972 Mlig455_011137 {REF} {Length: 173} {NoTransDecoderORF}
62. MligTC455_07101 46 0.96 Mlig455_062761

Neo: -

Age: Down-Up-Down

 POU4F1 1.809 - - 0.959 - - 0.850 Mlig455_062761 {REF} {Length: 2816} {Pfam: Pou domain - N-terminal to homeobox domain [PF00157.19, score=109.3]; Homeodomain [PF00046.31, score=67.1]; Helix-turn-helix domain [PF13560.8, score=22.0]} {Human: ENSG00000152192, POU4F1, POU class 4 homeobox 1, [RH, Score=271, Expect=7e-87]; ENSG00000151615, POU4F2, POU class 4 homeobox 2, [RH, Score=269, Expect=4e-86]; ENSG00000091010, POU4F3, POU class 4 homeobox 3, [RH, Score=267, Expect=2e-86]} {Mouse: ENSMUSG00000048349, Pou4f1, POU domain, class 4, transcription factor 1, [RH, Score=271, Expect=6e-87]; ENSMUSG00000031688, Pou4f2, POU domain, class 4, transcription factor 2, [RH, Score=268, Expect=3e-86]; ENSMUSG00000024497, Pou4f3, POU domain, class 4, transcription factor 3, [RH, Score=266, Expect=2e-86]} {Dmel: FBgn0000028, acj6, abnormal chemosensory jump 6, [RH, Score=265, Expect=3e-85]} {Celegans: WBGene00006818, unc-86, Transcription factor unc-86, [RH, Score=236, Expect=4e-75]} {Smed: dd_Smed_v6_15555_0_1, dd_Smed_v6_15555_0_1, [RH, Score=305, Expect=5e-101]} {RNA1509_57422} {RNA1310_8139.2} {RNA815_32659}
63. MligTC455_50794 32 0.67 Mlig455_026944, Mlig455_027032, Mlig455_027095

Neo: -

Age: -

 1.808 - - - - 0.828 0.980

Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317}

Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317}

Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317}
64. MligTC455_53843 1448 30.17 Mlig455_048664

Neo: -

Age: logFC(26M/2M)=0.488

 1.807 - - 0.854 - - 0.953 Mlig455_048664 {REF} {Length: 1660} {RNA1509_15580} {RNA1310_24090, RNA1509_15580} {RNA1509_15580, RNA815_10676.2}
65. MligTC455_13376 101 2.1 Mlig455_040613

Neo: -

Age: -

Region-specific R2: 4.973

Region-enriched R2: 6.158/0.00016

 1.804 - - - 0.968 - 0.836 Mlig455_040613 {REF} {Length: 2807} {RNA1310_27894} {RNA815_60961}
66. MligTC455_26092 67 1.39 Mlig455_048489

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.677

Region-enriched R2: 4.303/0.01110

 1.798 - - - 0.837 - 0.961 Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719}
67. MligTC455_53233 1483 30.9 Mlig455_037746, Mlig455_069921

Neo: -

Age: -

Region-specific R2: 7.323

Region-enriched R2: 7.524/0.00000

Regeneration-downregulated R2: -3.635

Regeneration-depleted R2: -3.635

 PKD2 1.796 - - - 0.825 - 0.971

Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1}

Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1}
68. MligTC455_15536 41 0.86 Mlig455_030649

Neo: -

Age: -

 1.793 - - - 0.828 - 0.965 Mlig455_030649 {REF} {Length: 1146} {RNA1310_33769.1} {RNA815_16068}
69. MligTC455_43412 88 1.82 Mlig455_057184

Neo: -

Age: -

 ANKRD60 1.793 - - 0.843 - - 0.950 Mlig455_057184 {REF} {Length: 1347} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=42.6]; Ankyrin repeat [PF13606.8, score=33.4]; Ankyrin repeats (many copies) [PF13857.8, score=33.2]; Ankyrin repeat [PF00023.32, score=32.8]; Ankyrin repeats (many copies) [PF13637.8, score=23.4]} {Human: ENSG00000124227, ANKRD60, ankyrin repeat domain 60, [Score=79.3, Expect=5e-16]} {Mouse: ENSMUSG00000027517, Ankrd60, ankyrin repeat domain 60, [Score=70.1, Expect=4e-13]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=50.8, Expect=1e-06]} {Celegans: WBGene00003196, mel-11, MEL-11, [Score=51.6, Expect=6e-07]} {Smed: dd_Smed_v6_8330_0_1, dd_Smed_v6_8330_0_1, [Score=129, Expect=1e-33]} {RNA1310_18551} {RNA815_10264.1}
70. MligTC455_15087 28 0.59 Mlig455_036738

Neo: -

Age: -

 1.792 - - - - 0.822 0.970 Mlig455_036738 {REF} {Length: 821} {RNA1509_18025} {RNA1310_92583} {RNA815_44681}
71. MligTC455_29138 150 3.13 Mlig455_047030

Neo: -

Age: Up-Down-Up

 EFR3A 1.79 - - 0.972 - 0.818 - Mlig455_047030 {REF} {Length: 5267} {TRANSSPLICED} {Pfam: ZIP Zinc transporter [PF02535.24, score=66.2]} {Human: ENSG00000132294, EFR3A, EFR3 homolog A, [RH, Score=343, Expect=2e-103]; ENSG00000084710, EFR3B, EFR3 homolog B, [RH, Score=327, Expect=2e-97]} {Mouse: ENSMUSG00000015002, Efr3a, EFR3 homolog A, [Score=346, Expect=4e-104]} {Dmel: FBgn0086784, stmA, stambha A, [Score=315, Expect=4e-93]} {Celegans: WBGene00016311, C32D5.3, Protein EFR3 homolog, [Score=249, Expect=2e-69]} {Smed: dd_Smed_v6_3212_0_1, dd_Smed_v6_3212_0_1, [RH, Score=397, Expect=5e-123]} {RNA1509_14238} {RNA1310_2165.2} {RNA815_4536}
72. MligTC455_33039 312 6.51 Mlig455_032494

Neo: -

Age: Up-Down-Down

Region-enriched R2: 3.545/0.00267

 PKDREJ 1.79 - - 0.829 - - 0.961 Mlig455_032494 {REF} {Length: 11952} {Pfam: Polycystin cation channel [PF08016.14, score=289.9]; REJ domain [PF02010.17, score=90.4]; PLAT/LH2 domain [PF01477.25, score=68.4]; PKD domain [PF00801.22, score=57.9]; PKD domain [PF18911.2, score=36.7]; Ion transport protein [PF00520.33, score=36.3]; GPCR proteolysis site, GPS, motif [PF01825.23, score=30.0]; WSC domain [PF01822.21, score=23.3]} {Human: ENSG00000130943, PKDREJ, polycystin family receptor for egg jelly, [Score=267, Expect=1e-70]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=292, Expect=3e-78]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=136, Expect=2e-31]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [RH, Score=297, Expect=4e-80]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=1504, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814}
73. MligTC455_53339 361 7.52 Mlig455_044792, Mlig455_044816, Mlig455_055565

Neo: -

Age: -

Region-enriched R2: 2.402/0.04439

 DMBT1 1.789 - - 0.958 - - 0.831

Mlig455_044792 {REF} {Length: 2555} {Pfam: Zona pellucida-like domain [PF00100.25, score=90.4]; Scavenger receptor cysteine-rich domain [PF00530.20, score=77.7]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=8e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=58.2, Expect=3e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.9, Expect=9e-14]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134}

Mlig455_044816 {REF} {Length: 2732} {Pfam: Zona pellucida-like domain [PF00100.25, score=89.0]; Scavenger receptor cysteine-rich domain [PF00530.20, score=78.1]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=67.0, Expect=9e-11]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=8e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=73.6, Expect=1e-13]} {RNA1509_36885} {RNA1310_10008, RNA1509_36885} {RNA1509_36885, RNA815_6134}

Mlig455_055565 {REF} {Length: 2284} {Pfam: Scavenger receptor cysteine-rich domain [PF00530.20, score=79.3]; Zona pellucida-like domain [PF00100.25, score=35.8]} {Human: ENSG00000187908, DMBT1, deleted in malignant brain tumors 1, [Score=65.5, Expect=1e-10]} {Mouse: ENSMUSG00000008845, Cd163, CD163 antigen, [Score=56.6, Expect=4e-08]} {Smed: dd_Smed_v6_8185_0_1, dd_Smed_v6_8185_0_1, [Score=55.1, Expect=4e-08]} {RNA1509_36885} {RNA1310_10008} {RNA815_6134}
74. MligTC455_17729 11 0.22 Mlig455_005654

Neo: -

Age: -

 CALML3 1.779 - - 0.809 - - 0.970 Mlig455_005654 {REF} {Length: 1583} {Pfam: EF hand [PF00036.34, score=110.5]; EF-hand domain pair [PF13499.8, score=105.1]; EF hand [PF13202.8, score=91.2]; EF-hand domain [PF13405.8, score=79.3]; EF-hand domain pair [PF13833.8, score=78.4]; EF-hand domain [PF14658.8, score=37.1]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=33.1]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=30.8]; Dockerin type I domain [PF00404.20, score=25.0]; EF-hand domain [PF08976.13, score=22.6]} {Human: ENSG00000178363, CALML3, calmodulin like 3, [Score=105, Expect=4e-29]; ENSG00000143933, CALM2, calmodulin 2, [Score=103, Expect=1e-27]; ENSG00000160014, CALM3, calmodulin 3, [Score=102, Expect=9e-28]; ENSG00000198668, CALM1, calmodulin 1, [Score=102, Expect=8e-28]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=110, Expect=3e-31]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=105, Expect=4e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=104, Expect=6e-29]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=104, Expect=4e-29]} {RNA1310_77551} {RNA815_27181}
75. MligTC455_26766 638 13.3 Mlig455_017977

Neo: -

Age: Up-Down-Down

Region-specific R2: 4.360

Region-enriched R2: 3.395/0.00052

 1.773 - - 0.799 - - 0.974 Mlig455_017977 {REF} {Length: 2516} {Smed: dd_Smed_v6_10627_0_1, dd_Smed_v6_10627_0_1, [Score=249, Expect=3e-71]} {RNA1509_19813} {RNA1310_621} {RNA815_183.1}
76. MligTC455_33040 203 4.23 Mlig455_032497

Neo: -

Age: logFC(26M/2M)=0.515

Region-enriched R2: 4.005/0.00408

 PKD2L1 1.772 - - 0.811 - - 0.961 Mlig455_032497 {REF} {Length: 3318} {Pfam: Polycystin cation channel [PF08016.14, score=293.1]; Ion transport protein [PF00520.33, score=39.7]} {Human: ENSG00000107593, PKD2L1, polycystin 2 like 1, transient receptor potential cation channel, [Score=236, Expect=4e-66]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=261, Expect=3e-73]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=131, Expect=5e-31]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=180, Expect=1e-47]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=641, Expect=0.0]} {RNA1509_3444} {RNA1310_89} {RNA815_1814}
77. MligTC455_19278 4335 90.31 Mlig455_057304, Mlig455_070944

Neo: -

Age: logFC(26M/2M)=0.686

Region-specific R2: 5.590

Region-enriched R2: 5.465/0.00000
Region-enriched R3: 2.308/0.00629

 CHRNA10 1.772 - - - 0.813 - 0.959

Mlig455_057304 {REF} {Length: 1001} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=71.6]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=77.0, Expect=2e-16]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=75.9, Expect=4e-16]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=75.5, Expect=6e-16]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=73.9, Expect=2e-15]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=93.6, Expect=2e-22]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=100, Expect=5e-25]} {Smed: dd_Smed_v6_11955_0_1, dd_Smed_v6_11955_0_1, [Score=82.8, Expect=8e-19]} {RNA1509_23115} {RNA1310_34970} {RNA815_15305.1}

Mlig455_070944 {REF} {Length: 1060} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=88.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=95.9, Expect=6e-22]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=96.3, Expect=3e-22]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=94.7, Expect=1e-21]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=112, Expect=7e-28]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=118, Expect=4e-30]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=98.6, Expect=2e-23]} {RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1310_34970, RNA1509_23115, RNA1509_43907, RNA1509_9432} {RNA1509_23115, RNA1509_43907, RNA1509_9432, RNA815_15305.1}
78. MligTC455_34524 155 3.22 Mlig455_021291

Neo: -

Age: Down-Up-Down

Region-specific R2: 4.905

Region-enriched R2: 4.200/0.01842

 1.772 - - 0.815 - - 0.957 Mlig455_021291 {REF} {Length: 1478} {NoTransDecoderORF} {RNA1509_56543} {RNA1310_26920, RNA1509_56543} {RNA1509_56543, RNA815_11718}
79. MligTC455_19276 1694 35.28 Mlig455_057303

Neo: -

Age: Down-Down-Up

Region-specific R2: 5.711

Region-enriched R2: 6.117/0.00000
Region-enriched R3: 2.663/0.00058

 1.77 - - - 0.811 - 0.959 Mlig455_057303 {REF} {Length: 1196} {Pfam: TATA-binding related factor (TRF) of subunit 20 of Mediator complex [PF08612.13, score=80.6]} {Smed: dd_Smed_v6_9879_0_1, dd_Smed_v6_9879_0_1, [RH, Score=73.9, Expect=1e-15]} {RNA1509_58478} {RNA1310_35292} {RNA815_20171}
80. MligTC455_14034 25 0.52 Mlig455_001196

Neo: -

Age: -

 1.769 - - 0.819 - - 0.950 Mlig455_001196 {REF} {Length: 1906} {RNA1509_36146} {RNA1310_50710} {RNA815_46064}
81. MligTC455_44381 50 1.04 Mlig455_034187

Neo: -

Age: -

 1.768 - - - 0.788 - 0.980 Mlig455_034187 {REF} {Length: 1133} {Pfam: WSC domain [PF01822.21, score=41.3]} {RNA1310_44307} {RNA815_33128}
82. MligTC455_53118 133 2.76 Mlig455_029477

Neo: -

Age: -

 CHRNA2 1.768 - - 0.981 - 0.787 - Mlig455_029477 {REF} {Length: 3006} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.2]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=212, Expect=1e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=210, Expect=4e-59]} {Mouse: ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=209, Expect=3e-59]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=207, Expect=2e-59]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=204, Expect=1e-58]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=204, Expect=4e-58]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=208, Expect=1e-57]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=202, Expect=2e-57]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=437, Expect=6e-147]} {RNA1509_18288} {RNA1310_21192} {RNA815_24334}
83. MligTC455_22098 31 0.66 Mlig455_004396, Mlig455_037219

Neo: -

Age: -

 1.765 - - - 0.785 - 0.980

Mlig455_004396 {REF} {Length: 1521} {RNA1310_40784}

Mlig455_037219 {REF} {Length: 1583} {RNA1310_63625}
84. MligTC455_21389 173 3.6 Mlig455_012718

Neo: -

Age: -

 SLC9B2 1.764 - - 0.793 - - 0.971 Mlig455_012718 {REF} {Length: 3209} {Pfam: Sodium/hydrogen exchanger family [PF00999.23, score=114.5]; Sodium/glutamate symporter [PF03616.16, score=18.4]} {Human: ENSG00000164038, SLC9B2, solute carrier family 9 member B2, [Score=320, Expect=3e-100]} {Mouse: ENSMUSG00000050150, Slc9b1, solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1, [RH, Score=303, Expect=5e-94]} {Dmel: FBgn0031865, Nha1, Na[+]/H[+] hydrogen antiporter 1, [Score=257, Expect=4e-75]} {Celegans: WBGene00009618, F41E7.2, [Score=136, Expect=9e-34]} {Smed: dd_Smed_v6_7736_0_2, dd_Smed_v6_7736_0_2, [RH, Score=359, Expect=2e-116]} {RNA1509_19376} {RNA1310_19487} {RNA815_52764}
85. MligTC455_31370 27 0.55 Mlig455_035805

Neo: -

Age: -

 ASIC1 1.763 - - 0.787 - - 0.976 Mlig455_035805 {REF} {Length: 3035} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.8]} {Human: ENSG00000110881, ASIC1, acid sensing ion channel subunit 1, [Score=60.1, Expect=8e-09]} {Mouse: ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=58.5, Expect=2e-08]} {Smed: dd_Smed_v6_16346_0_1, dd_Smed_v6_16346_0_1, [Score=107, Expect=3e-24]} {RNA1310_49983} {RNA815_25991}
86. MligTC455_34525 52 1.08 Mlig455_021566

Neo: -

Age: Down-Up-Down

 GNAI1 1.761 - - 0.764 - - 0.997 Mlig455_021566 {REF} {Length: 3532} {Pfam: G-protein alpha subunit [PF00503.22, score=404.9]; ADP-ribosylation factor family [PF00025.23, score=56.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=20.1]; Gtr1/RagA G protein conserved region [PF04670.14, score=19.4]} {Human: ENSG00000127955, GNAI1, G protein subunit alpha i1, [Score=486, Expect=2e-171]; ENSG00000114353, GNAI2, G protein subunit alpha i2, [Score=481, Expect=3e-169]; ENSG00000065135, GNAI3, G protein subunit alpha i3, [Score=474, Expect=1e-166]} {Mouse: ENSMUSG00000057614, Gnai1, guanine nucleotide binding protein (G protein), alpha inhibiting 1, [Score=486, Expect=2e-171]; ENSMUSG00000032562, Gnai2, guanine nucleotide binding protein (G protein), alpha inhibiting 2, [Score=475, Expect=5e-167]; ENSMUSG00000000001, Gnai3, guanine nucleotide binding protein (G protein), alpha inhibiting 3, [Score=474, Expect=1e-166]} {Dmel: FBgn0001104, Galphai, G protein alpha i subunit, [Score=468, Expect=2e-164]} {Celegans: WBGene00001648, goa-1, Guanine nucleotide-binding protein G(o) subunit alpha, [Score=446, Expect=5e-156]} {Smed: dd_Smed_v6_12112_0_1, dd_Smed_v6_12112_0_1, [RH, Score=598, Expect=0.0]} {RNA1509_45426} {RNA1310_26920, RNA1509_45426} {RNA1509_45426, RNA815_11718}
87. MligTC455_24108 17 0.35 Mlig455_019116

Neo: -

Age: -

 KCNK16 1.758 - - 0.778 - - 0.980 Mlig455_019116 {REF} {Length: 1389} {Pfam: Ion channel [PF07885.18, score=118.0]; Ion transport protein [PF00520.33, score=29.1]} {Human: ENSG00000095981, KCNK16, potassium two pore domain channel subfamily K member 16, [Score=155, Expect=5e-44]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [RH, Score=141, Expect=3e-37]} {Dmel: FBgn0037690, Task7, TWIK-related acid-sensitive K[+] channel 7, [Score=110, Expect=3e-27]} {Celegans: WBGene00006696, twk-46, TWiK family of potassium channels, [Score=115, Expect=3e-29]} {Smed: dd_Smed_v6_9028_0_1, dd_Smed_v6_9028_0_1, [Score=121, Expect=4e-31]} {RNA1310_125949}
88. MligTC455_46452 134 2.79 Mlig455_048151

Neo: -

Age: -

Region-specific R2: 6.389

Region-enriched R2: 7.075/0.00014

Regeneration-downregulated R2: -3.162

Regeneration-depleted R2: -3.162

 1.758 - - 0.768 - - 0.990 Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352}
89. MligTC455_24515 14 0.28 Mlig455_033346, Mlig455_033365

Neo: -

Age: -

 HTR1B 1.757 - - 0.759 - - 0.998

Mlig455_033346 {REF} {Length: 1493} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.5]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=4e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=189, Expect=2e-54]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=176, Expect=4e-50]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=218, Expect=5e-66]} {RNA1310_132724}

Mlig455_033365 {REF} {Length: 1935} {TRANSSPLICED} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=216.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=24.0]} {Human: ENSG00000135312, HTR1B, 5-hydroxytryptamine receptor 1B, [Score=211, Expect=7e-63]} {Mouse: ENSMUSG00000021478, Drd1, dopamine receptor D1, [RH, Score=191, Expect=4e-55]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=182, Expect=7e-51]} {Celegans: WBGene00001052, dop-1, DOPamine receptor, [Score=178, Expect=8e-51]} {Smed: dd_Smed_v6_26479_0_1, dd_Smed_v6_26479_0_1, [Score=216, Expect=2e-65]} {RNA1310_132724}
90. MligTC455_42994 1521 31.7 Mlig455_035840

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.356

Region-enriched R2: 1.854/0.00052

 1.757 - - 0.790 - - 0.967 Mlig455_035840 {REF} {Length: 1436} {RNA1509_29485, RNA1509_42231} {RNA1310_26640, RNA1509_29485, RNA1509_42231} {RNA1509_29485, RNA1509_42231, RNA815_37260}
91. MligTC455_45719 94 1.96 Mlig455_056535

Neo: -

Age: -

 CHRNA6 1.757 - - 0.806 - - 0.951 Mlig455_056535 {REF} {Length: 2532} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=102.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=75.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=127, Expect=1e-31]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=125, Expect=4e-31]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=125, Expect=5e-31]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=120, Expect=1e-29]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=117, Expect=4e-28]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=125, Expect=3e-31]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=122, Expect=4e-30]} {RNA1509_7752} {RNA1310_37530} {RNA815_18433}
92. MligTC455_15836 36 0.74 Mlig455_000292

Neo: -

Age: Up-Down-Down

 PLEKHG5 1.755 - - - - 0.790 0.965 Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026}
93. MligTC455_46638 16 0.33 Mlig455_010743

Neo: -

Age: -

 LMX1B 1.754 - - 0.784 - - 0.970 Mlig455_010743 {REF} {Length: 2197} {Pfam: LIM domain [PF00412.24, score=101.8]; Homeodomain [PF00046.31, score=64.1]; Homeobox KN domain [PF05920.13, score=27.5]; Auxin canalisation [PF05703.13, score=20.5]} {Human: ENSG00000136944, LMX1B, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=3e-76]; ENSG00000162761, LMX1A, LIM homeobox transcription factor 1 alpha, [RH, Score=238, Expect=3e-75]} {Mouse: ENSMUSG00000038765, Lmx1b, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=2e-76]; ENSMUSG00000026686, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=233, Expect=2e-73]} {Dmel: FBgn0052105, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=236, Expect=7e-72]} {Celegans: WBGene00002988, lim-6, LIM domain family, [Score=182, Expect=1e-54]} {Smed: dd_Smed_v6_13371_0_1, dd_Smed_v6_13371_0_1, [RH, Score=171, Expect=2e-49]} {RNA1310_76849}
94. MligTC455_15745 27 0.56 Mlig455_040119, Mlig455_067332

Neo: -

Age: -

 ANGPTL2 1.753 - - 0.773 - - 0.980

Mlig455_040119 {REF} {Length: 1066} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=123.8]; PAN domain [PF00024.28, score=20.3]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=102, Expect=5e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=100, Expect=2e-23]; ENSG00000116147, TNR, tenascin R, [Score=100, Expect=2e-23]; ENSG00000120332, TNN, tenascin N, [Score=97.8, Expect=3e-22]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=8e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=101, Expect=1e-23]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=100, Expect=8e-24]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=100, Expect=1e-23]} {Dmel: FBgn0050280, CG30280, [Score=104, Expect=2e-26]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=105, Expect=2e-25]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241}

Mlig455_067332 {REF} {Length: 1104} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=125.5]; PAN domain [PF00024.28, score=19.2]} {Human: ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=104, Expect=1e-24]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]; ENSG00000116147, TNR, tenascin R, [Score=101, Expect=2e-23]} {Mouse: ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=103, Expect=2e-24]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=103, Expect=1e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=102, Expect=7e-25]; ENSMUSG00000015829, Tnr, tenascin R, [Score=101, Expect=1e-23]} {Dmel: FBgn0050280, CG30280, [Score=107, Expect=2e-27]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=107, Expect=4e-26]} {RNA1509_58115} {RNA1310_32877} {RNA815_17241}
95. MligTC455_49451 16 0.34 Mlig455_030374

Neo: -

Age: -

 NOX5 1.753 - - - - 0.773 0.980 Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457}
96. MligTC455_24270 71 1.47 Mlig455_005120

Neo: -

Age: -

 CHRNA7 1.752 - - - 0.794 - 0.958 Mlig455_005120 {REF} {Length: 1530} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=66.6]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=148, Expect=4e-39]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=147, Expect=5e-39]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=145, Expect=4e-38]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=146, Expect=2e-38]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=1e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=135, Expect=5e-34]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [Score=134, Expect=9e-35]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=133, Expect=4e-34]} {RNA1509_43533} {RNA1310_20839.2} {RNA815_22406}
97. MligTC455_38949 105 2.19 Mlig455_065209

Neo: -

Age: -

Region-specific R2: 7.633

Region-enriched R2: 10.088/0.00000

 1.752 - - 0.772 - - 0.980 Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329}
98. MligTC455_09456 47 0.97 Mlig455_029993

Neo: -

Age: -

Region-enriched R2: 5.041/0.00960

 1.75 - - 0.756 - - 0.994 Mlig455_029993 {REF} {Length: 3167} {RNA1509_44134} {RNA1310_31411} {RNA815_45870}
99. MligTC455_46691 41 0.85 Mlig455_018781, Mlig455_018951

Neo: -

Age: Up-Down-Down

 1.75 - - 0.780 - - 0.970

Mlig455_018781 {REF} {Length: 1694} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_43489} {RNA815_41340}

Mlig455_018951 {REF} {Length: 2466} {Celegans: WBGene00021142, clec-133, C-type LECtin, [RH, Score=52.0, Expect=6e-08]} {RNA1310_38733.1} {RNA815_41340}
100. MligTC455_46637 18 0.37 Mlig455_010742

Neo: Irradiation

Age: Down-Up-Down

Region-enriched R2: 6.787/0.03510

 LMX1B 1.748 - - 0.784 - - 0.964 Mlig455_010742 {REF} {Length: 2975} {Pfam: LIM domain [PF00412.24, score=101.8]; Homeodomain [PF00046.31, score=64.1]; Homeobox KN domain [PF05920.13, score=27.5]; Auxin canalisation [PF05703.13, score=20.5]} {Human: ENSG00000136944, LMX1B, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=3e-76]; ENSG00000162761, LMX1A, LIM homeobox transcription factor 1 alpha, [RH, Score=238, Expect=3e-75]} {Mouse: ENSMUSG00000038765, Lmx1b, LIM homeobox transcription factor 1 beta, [RH, Score=241, Expect=2e-76]; ENSMUSG00000026686, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=233, Expect=2e-73]} {Dmel: FBgn0052105, Lmx1a, LIM homeobox transcription factor 1 alpha, [RH, Score=236, Expect=7e-72]} {Celegans: WBGene00002988, lim-6, LIM domain family, [Score=182, Expect=1e-54]} {Smed: dd_Smed_v6_13371_0_1, dd_Smed_v6_13371_0_1, [RH, Score=171, Expect=2e-49]} {RNA1509_10207} {RNA1310_5646.2} {RNA815_25330}

There are 662 more genes with r >= 0.95  Show all


Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA